203 related articles for article (PubMed ID: 24752895)
21. A repressive role for prohibitin in estrogen signaling.
He B; Feng Q; Mukherjee A; Lonard DM; DeMayo FJ; Katzenellenbogen BS; Lydon JP; O'Malley BW
Mol Endocrinol; 2008 Feb; 22(2):344-60. PubMed ID: 17932104
[TBL] [Abstract][Full Text] [Related]
22. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
23. SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells.
Hammerich-Hille S; Kaipparettu BA; Tsimelzon A; Creighton CJ; Jiang S; Polo JM; Melnick A; Meyer R; Oesterreich S
J Biol Chem; 2010 Feb; 285(6):3608-3616. PubMed ID: 19901029
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.
Ying S; Dünnebier T; Si J; Hamann U
PLoS One; 2013; 8(9):e75695. PubMed ID: 24086615
[TBL] [Abstract][Full Text] [Related]
25. p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.
Fritah A; Saucier C; Mester J; Redeuilh G; Sabbah M
Mol Cell Biol; 2005 Mar; 25(6):2419-30. PubMed ID: 15743834
[TBL] [Abstract][Full Text] [Related]
26. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
27. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells.
Wang Y; Zhou D; Phung S; Masri S; Smith D; Chen S
Mol Endocrinol; 2011 Jan; 25(1):72-82. PubMed ID: 21084382
[TBL] [Abstract][Full Text] [Related]
28. Synergism between a half-site and an imperfect estrogen-responsive element, and cooperation with COUP-TFI are required for estrogen receptor (ER) to achieve a maximal estrogen-stimulation of rainbow trout ER gene.
Petit FG; Métivier R; Valotaire Y; Pakdel F
Eur J Biochem; 1999 Jan; 259(1-2):385-95. PubMed ID: 9914518
[TBL] [Abstract][Full Text] [Related]
29. Role of CCCTC binding factor (CTCF) and cohesin in the generation of single-cell diversity of protocadherin-α gene expression.
Monahan K; Rudnick ND; Kehayova PD; Pauli F; Newberry KM; Myers RM; Maniatis T
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9125-30. PubMed ID: 22550178
[TBL] [Abstract][Full Text] [Related]
30. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.
Fiorito E; Sharma Y; Gilfillan S; Wang S; Singh SK; Satheesh SV; Katika MR; Urbanucci A; Thiede B; Mills IG; Hurtado A
Nucleic Acids Res; 2016 Dec; 44(22):10588-10602. PubMed ID: 27638884
[TBL] [Abstract][Full Text] [Related]
31. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
32. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
33. SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1.
Wagner S; Weber S; Kleinschmidt MA; Nagata K; Bauer UM
J Biol Chem; 2006 Sep; 281(37):27242-50. PubMed ID: 16861234
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
35. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
[TBL] [Abstract][Full Text] [Related]
36. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
37. [Chromatin remodeling in estrogen-dependent and independent human breast cancer cell lines].
Chailleux C; Giamarchi C; Morales V; Moro F; Richard-Foy H
Ann Endocrinol (Paris); 2000 May; 61(2):130-5. PubMed ID: 10891664
[TBL] [Abstract][Full Text] [Related]
38. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation.
McInerney EM; Katzenellenbogen BS
J Biol Chem; 1996 Sep; 271(39):24172-8. PubMed ID: 8798658
[TBL] [Abstract][Full Text] [Related]
39. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.
Lal S; Allan A; Markovic D; Walker R; Macartney J; Europe-Finner N; Tyson-Capper A; Grammatopoulos DK
Sci Signal; 2013 Jul; 6(282):ra53. PubMed ID: 23821771
[TBL] [Abstract][Full Text] [Related]
40. Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.
Talukder AH; Gururaj A; Mishra SK; Vadlamudi RK; Kumar R
Mol Cell Biol; 2004 Aug; 24(15):6581-91. PubMed ID: 15254226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]